Imbrium Therapeutics, an operating subsidiary of Purdue Pharma, is advancing its novel, potentially first-in-class small molecule IMB-115 (previously referred to as IT-1315) to a Phase 2 clinical study following favorable results from Phase 1 studies […]
Gamida Cell and Lonza announced that the companies have entered into a strategic manufacturing agreement. The agreement provides for the future commercial production after potential FDA approval of omidubicel, Gamida Cell’s investigational advanced cell therapy […]
SMi Reports: New brochure released for the 2019 Pharmaceutical Cleanroom Technology Europe conference taking place in London on 9th and 10th October Since the release of the agenda for the Inaugural Pharmaceutical Cleanroom Technology Europe […]
SMi reports: Taro Pharmaceuticals, Purdue Pharma and Sakari Consultants to present at HPAPI USA taking place on October 21st – 22nd in Boston With a massive growth within the HPAPI market, manufacturers cannot afford to […]
SMi Reports: Interview with expert speaker from Alliance for Safe Biologic Medicines (ASBM) released for the 2019 Biosimilars conference The 10th annual Biosimilars conference will be returning to London on 25th and 26th September 2019, […]